If you're feeling more sudden urges to run to the bathroom as you age, you're not alone. A new study suggests postmenopausal women aged 45 to 54 years are more likely to have overactive bladder (OAB) ...

“I have women that will start working with me and come back for follow up appointments and say, ‘I started to speak with my friends about this, and it’s—I never knew how many people had this problem,' ...

Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...

Do you often feel a sudden, intense urge to urinate that disrupts your daily life? If so, you may be experiencing one of the most common overactive bladder symptoms. Understanding the signs to look ...

LAS VEGAS -- Overactive bladder (OAB) symptoms in women improved rapidly and significantly following a single treatment with transvaginal radiofrequency (RF) nerve ablation, a small prospective study ...

A minimally invasive, coin-sized implantable device was effective in treating overactive bladder (OAB) syndrome, researchers found. In a prospective, single-arm, open-label study funded by the ...

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

If frequent bathroom trips disrupt your life, you are not alone. Women's health expert Kirtly Jones, MD, talks to urogynecologist Whitney Hendrickson, MD, about the complexities of overactive bladder ...

Gemtesa is an oral, once-daily, small molecule beta-3 adrenergic agonist. Gemtesa ® (vibegron; Urovant Sciences) is now available for the treatment of overactive bladder (OAB) with symptoms of urge ...

Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an ...